-
Signature
-
/s/ Kathy Card Beckles, Attorney-in-fact
-
Issuer symbol
-
VRSK
-
Transactions as of
-
03 Jul 2025
-
Net transactions value
-
-$1,141,886
-
Form type
-
4
-
Filing time
-
07 Jul 2025, 16:11:43 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Daffan Nicholas |
Chief Information Officer |
C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY |
/s/ Kathy Card Beckles, Attorney-in-fact |
07 Jul 2025 |
0001803783 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VRSK |
Common Stock |
Options Exercise |
$285,896 |
+2,749 |
+4.8% |
$104.00 |
59,450 |
03 Jul 2025 |
Direct |
|
| transaction |
VRSK |
Common Stock |
Options Exercise |
$202,578 |
+1,882 |
+3.2% |
$107.64 |
61,332 |
03 Jul 2025 |
Direct |
|
| transaction |
VRSK |
Common Stock |
Sale |
$1,630,360 |
-5,419 |
-8.8% |
$300.86 |
55,913 |
03 Jul 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VRSK |
Stock Option |
Options Exercise |
$0 |
-2,749 |
-20% |
$0.000000 |
10,998 |
03 Jul 2025 |
Common Stock |
2,749 |
$104.00 |
Direct |
F2 |
| transaction |
VRSK |
Stock Option |
Options Exercise |
$0 |
-1,882 |
-20% |
$0.000000 |
7,531 |
03 Jul 2025 |
Common Stock |
1,882 |
$107.64 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: